Recent Quotes (30 days)

You have no recent quotes
chg | %

Omega Diagnostics Group Plc  

(Public, LON:ODX)   Watch this stock  
Find more results forODX
17.60
-0.15 (-0.85%)
Real-time:   11:39am BST
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 17.60 - 17.95
52 week 12.02 - 21.00
Open 17.75
Vol / Avg. 20,641.00/147,897.00
Mkt cap 15.00M*
P/E 20.00
Div/yield     -
EPS 0.01*
Shares 85.22M
Beta     -
Inst. own     -
*GBP
Aug 26, 2013
Omega Diagnostics Group PLC Annual General Meeting Add to calendar
Jul 1, 2013
Preliminary 2012 Omega Diagnostics Group PLC Earnings Release Add to calendar
Jun 10, 2013
Omega Diagnostics Group PLC General Meeting
  

Key stats and ratios

Q3 (Sep '12) 2012
Net profit margin 6.08% 4.74%
Operating margin 2.64% 4.65%
EBITD margin - 11.10%
Return on average assets 4.02% 3.09%
Return on average equity 5.00% 4.01%
Employees 107 -
Carbon Disclosure Rating - -

Address

Omega House, Hillfoots Business Village
ALVA, FK12 5DQ
United Kingdom - Map
+44-1259-763030 (Phone)
+44-1259-761853 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance
Discussion Group - Google Finance

Description

Omega Diagnostics Group PLC is engaged in manufacture, development and distribution of medical diagnostics products. It operates in three divisions: Allergy and Autoimmune, Food Intolerance and Infectious and Other. The Company is focused on selling a range of specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market. The Allergy and Autoimmune division specializes in the research, development, production and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases. The Food Intolerance division specializes in the research, development and production of kits to aid the detection of immune reactions to food. It also provides clinical analysis to the general public, and clinics, as well as supplying the consumer Food Detective test. The Infectious diseases division specializes in the research, development and production and marketing of kits to aid the diagnosis of infectious diseases.

Officers and directors

Andrew Shepherd Chief Executive, Managing Director, Executive Director
Kieron Harbinson Group Finance Director, Company Secretary, Executive Director
Iain Logan Group Financial Controller
Jag Grewal Group Sales and Marketing Director, Executive Director
Karsten Brenzke Site Manager of Omega Diagnostics GmbH
Mike Gordon Group Operations Director
Prashant Maniar Managing Director of Omega Dx (Asia) Pvt Limited
Edward Valente Group Research and Development Director
Jamie Yexley Site Manager of Genesis Diagnostics Limited and Cambridge Nutritional Sciences Limited
David Eric Evans Independent Non-Executive Chairman of the Board
Age: 52